Data / New clinical trials / Neoplasm Metastasis

Neoplasm Metastasis trials: 365 new since Nov 2024

Name: New Neoplasm Metastasis clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Neoplasm Metastasis clinical trials: 365 rows for $18.25, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 16 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/neoplasm-metastasis, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 5, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

365 clinical studies in Neoplasm Metastasis were first posted on ClinicalTrials.gov from November 12, 2024 to November 5, 2026; 138 have an industry sponsor and 322 are recruiting or about to. The newest, NCT07920198, was posted on November 5, 2026: Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the... (Azienda Ospedaliero-Universitaria di Modena).

The request: Every new Neoplasm Metastasis clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

365New trials
138Industry sponsored
322Recruiting or not yet
November 5, 2026Latest posted

Newest trials

The newest 100 of 365, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 5, 2026	NCT07920198	Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient...	Azienda Ospedaliero-Universitaria di Modena	Observational	Recruiting	Cushing s Syndrome, Cushing Disease, Cushing Disease Due to Increased ACTH Secretion, Mild Autonomous Cortisol...	2,000	Italy	clinicaltrials.gov
November 5, 2026	NCT07919834	Ultrasonographic Tissue Thickness After Complex Decongestive Therapy in Lower-Limb Lymphedema	Kayseri City Hospital	Observational	Completed	Lymphedema of Lower Limb, Lymphedema, Secondary	40	Turkey (Türkiye)	clinicaltrials.gov
November 5, 2026	NCT07918872	Effect of Squatting Position in the Second Stage of Labor on Birth Outcomes	Ege University	Not applicable	Recruiting	Nulliparity, Labor Stage, Second, Birth Position, Squatting Position	60	Turkey (Türkiye)	clinicaltrials.gov
November 2, 2026	NCT07909031	CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors	Crescent Biopharma, Inc.	Phase 1/2	Recruiting	Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)...	219	United States	clinicaltrials.gov
October 29, 2026	NCT07905313	Study of Trastuzumab Deruxtecan in Combination With Stereotactic Radiosurgery in Patients With HER2-Positive Metastatic Breast Cancer and...	Azienda Ospedaliero-Universitaria Careggi	Phase 2	Not yet recruiting	Breast Cancer (Advanced/Metastatic)	60		clinicaltrials.gov
October 29, 2026	NCT07904494	Immune-Related Adverse Events and Clinical Outcomes of First-Line Immunotherapy in Egyptian Patients With Unresectable Hepatocellular...	Assiut University	Observational	Not yet recruiting	Hepatocellular Carcinoma, Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Non-Resectable, Hepatocellular...	294	Egypt	clinicaltrials.gov
October 29, 2026	NCT07904013	Impact of a Radiologic and Immunologic Signature on Cerebral Efficacy of Treatments in Lung Cancers With Brain Metastasis	University Hospital, Bordeaux	Observational	Not yet recruiting	Carcinoma, Non-Small-Cell Lung, Brain Neoplasms, Neoplasm Metastasis	38	France	clinicaltrials.gov
October 29, 2026	NCT07903415	A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.	Pfizer	Phase 1	Recruiting	Pancreatic Ductal Adenocarcinoma, Esophageal Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC), Gastric Carcinoma...	280	United States	clinicaltrials.gov
October 29, 2026	NCT07902544	Station-Specific Lymph Node Metastasis After Neoadjuvant Chemoimmunotherapy for Middle Thoracic Esophageal Squamous Cell Carcinoma	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	Observational	Completed	Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Metastasis	717		clinicaltrials.gov
October 28, 2026	NCT07901803	Aspirin and PAClitaxel in Head & Neck Squamous Cell Carcinoma	Washington University School of Medicine	Phase 2	Not yet recruiting	Head and Neck (HNSCC), Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Head and Neck...	40	United States	clinicaltrials.gov
October 28, 2026	NCT07900984	A Retrospective Registry of Intelliblate DUAL Channel Microwave Ablation	Varian, a Siemens Healthineers Company	Observational	Not yet recruiting	Liver Ablation, Liver Cancer, Liver Cancer (Primary and Metastatic)	63		clinicaltrials.gov
October 27, 2026	NCT07899632	A Study of MDSY-1240, a STAT3 Degrader, for the Treatment of Hematologic Malignancies and Advanced Solid Tumors	Medsyn Biopharma, LLC	Phase 1/2	Not yet recruiting	Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic, Ovarian Cancer...	75		clinicaltrials.gov
October 27, 2026	NCT07899463	ESR1 Mutations in Metastatic Hormone Receptor-Positive Breast Cancer in the Greek Population	Hellenic Cooperative Oncology Group	Observational	Recruiting	ESR1 Gene Mutation, Breast Cancer (Locally Advanced or Metastatic), Hormon Receptor Positive Breast Cancer	500	Greece	clinicaltrials.gov
October 26, 2026	NCT07893535	An Investigational Study of BON-106 in Adults With Advanced or Metastatic Solid Tumors	BeOne Medicines	Phase 1	Not yet recruiting	Solid Tumor, Advanced Solid Tumor, Metastatic Solid Tumor	96		clinicaltrials.gov
October 16, 2026	NCT07878988	This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic...	LTZ Therapeutics, Inc.	Phase 1	Recruiting	Colorectal Cancer, Advanced/Metastatic Solid Tumor, Solid Tumor (Phase I), EPCAM, Colon Cancer	152	United States	clinicaltrials.gov
October 13, 2026	NCT07870837	Head-to-Head (H2H) Comparison of Ambulatory Cardiac ECG Monitors in Japan	iRhythm Technologies, Inc.	Not applicable	Not yet recruiting	Atrial Fibrillation (AF), Atrial Flutter, Supraventricular Tachycardia (SVT), Ventricular Tachycardia (VT), Ventricular...	130	Japan	clinicaltrials.gov
October 13, 2026	NCT07869836	BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial...	SystImmune Inc.	Phase 3	Recruiting	Urothelial Cancer, Metastatic Urothelial Cancer, Bladder Cancer, Bladder Cancer (BC), Bladder (Urothelial, Transitional...	520	United States	clinicaltrials.gov
October 7, 2026	NCT07863986	Predictive Factors for Response to Lutetium-177 PSMA Radioligand Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer	Lithuanian University of Health Sciences	Observational	Recruiting	Prostate Cancer, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Neoplasm Metastases	70	Lithuania	clinicaltrials.gov
October 7, 2026	NCT07863024	Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets MET...	Regeneron Pharmaceuticals	Phase 1/2	Not yet recruiting	Advanced Solid Tumors	320		clinicaltrials.gov
October 6, 2026	NCT07860866	Blood Biomarkers for Breast Cancer Treatment Response	University of Pittsburgh	Observational	Not yet recruiting	Breast Cancer (Advanced/Metastatic), ER Positive	200	United States	clinicaltrials.gov
October 6, 2026	NCT07860723	Estimating the Impact of Sexuality Education and Mobile Health Services on Reproductive Health and Empowerment Among Adolescents in Sierra...	Guttmacher Institute	Not applicable	Recruiting	Reproductive Health, Sexual Health, Contraception Behavior, Pregnancy (Unwanted), Empowerment, Agency, School Dropouts...	5,300	Sierra Leone	clinicaltrials.gov
October 6, 2026	NCT07859592	Labyrinthin Vaccination in Veterans With Lung Adenocarcinoma	VA Office of Research and Development	Phase 2	Not yet recruiting	Type and Grade of Toxicities, Demographic and Background Characteristics, Advanced, Metastatic, Recurrent...	30	United States	clinicaltrials.gov
October 5, 2026	NCT07856914	Paricalcitol Versus Pirfenidone for Improving Surgical Resectability in Patients With Peritoneal Cancer	Patrick Wagner, MD, FACS	Phase 2	Not yet recruiting	Peritoneal (Metastatic) Cancer, Peritoneal Carcinoma, Peritoneal Carcinosis, Peritoneal Cancer, Peritoneal...	74		clinicaltrials.gov
October 2, 2026	NCT07856394	Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With...	Mayo Clinic	Not applicable	Recruiting	Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm, Unresectable Solid Tumor, Malignant Tumor...	100	United States	clinicaltrials.gov
September 30, 2026	NCT07850882	A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for...	Jie Yuan，MD	Observational	Recruiting	Colorectal Cancer (CRC), Gastric Cancer (GC), Hepatocellular Carcinoma (HCC)	30	China	clinicaltrials.gov
September 30, 2026	NCT07850869	A Real-World Observational Study of Intratumoral H101 Oncolytic Adenovirus Combined With Immune Checkpoint Inhibitors for Advanced...	Jie Yuan，MD	Observational	Recruiting	Breast Cancer (Locally Advanced or Metastatic)	15	China	clinicaltrials.gov
September 30, 2026	NCT07848516	Change in Fat Fraction Quantification Before and After Treatment in Bone Metastases	Assiut University	Observational	Recruiting	Neoplasm Metastasis / Bone and Bones	84	Egypt	clinicaltrials.gov
September 28, 2026	NCT07844057	First-line Treatment in Locally Advanced or Metastastic Small Bowel Adenocarcinoma	Annika Kurreck	Phase 2	Not yet recruiting	Small-bowel Adenocarcinoma, Metastatic Disease, Chemotherapy Effect	86	Germany	clinicaltrials.gov
September 18, 2026	NCT07829185	Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer	University of Oklahoma	Phase 1	Recruiting	Pancreatic Ductal Adenocarcinoma (PDAC)	30	United States	clinicaltrials.gov
September 17, 2026	NCT07826780	The STRONG Nutrition Support Study for People With Pancreatic Cancer	UNC Lineberger Comprehensive Cancer Center	Not applicable	Not yet recruiting	Pancreas Cancer, Metastatic, Pancreas Carcinoma	80	United States	clinicaltrials.gov
September 17, 2026	NCT07824856	Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma	Sun Yat-sen University	Phase 2	Not yet recruiting	Nasopharyngeal Carcinoma, Neoplasm Metastasis, Lung Metastases, Liver Metastases, Oligometastatic Disease, Ablation...	138	China	clinicaltrials.gov
September 17, 2026	NCT07824791	Prediction of Postoperative Recurrence in Crohn's Disease	Sixth Affiliated Hospital, Sun Yat-sen University	Observational	Recruiting	Crohn Disease (CD), Postoperative Recurrence and Metastasis	250	China	clinicaltrials.gov
September 15, 2026	NCT07820644	A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease)	Cai Qingxian	Observational	Recruiting	Liver Cancer (Primary and Metastatic)	15,000	China	clinicaltrials.gov
September 14, 2026	NCT07817147	CREO - Microwave Ablation Feasibility Study	Banner Health	Not applicable	Recruiting	Pancreatic Cancer, Liver Cancer (Locally Advanced or Metastatic), Pancreatic Cancer Non-resectable, Pancreatic Cancer...	75	United States	clinicaltrials.gov
September 11, 2026	NCT07815834	FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled...	Fudan University	Phase 3	Recruiting	Colon Rectal Cancer Adenocarcinoma, Peritoneal (Metastatic) Cancer, Second-line Treatment, Radiation Therapy...	198	China	clinicaltrials.gov
September 10, 2026	NCT07811453	Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options	Charite University, Berlin, Germany	Not applicable	Not yet recruiting	Colorectal Neoplasms, Liver Neoplasms, Neoplasm Metastases, Colorectal Liver Metastases, Metastatic Colorectal Cancer...	260	Germany	clinicaltrials.gov
September 4, 2026	NCT07804875	Symptom Trajectory Approaches to Research	University of Wisconsin, Madison	Observational	Not yet recruiting	Advanced Cancer, Metastatic Disease, Cancer Treatment, Progressive Disease, Recurrent Cancer	228	United States	clinicaltrials.gov
September 3, 2026	NCT07803562	Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp	University of California, San Diego	Phase 2	Withdrawn	Uveal Melanoma, Metastatic	0	United States	clinicaltrials.gov
September 3, 2026	NCT07803549	The Effect of Self-Management Interventions Among Patients With Breast Cancer Related-Lymphedema	Al-Zaytoonah University of Jordan	Not applicable	Completed	Breast Cancer (Locally Advanced or Metastatic), Lymphedema Arm	100	Jordan	clinicaltrials.gov
September 3, 2026	NCT07802626	Adding Capivasertib to Standard Treatment in HR Positive, HER2 Negative Metastatic Breast Cancer Based on ctDNA Testing	SWOG Cancer Research Network	Phase 3	Not yet recruiting	HR Positive/HER-2 Negative Breast Cancer	1,084		clinicaltrials.gov
September 2, 2026	NCT07799974	Identification of Changes in Cancer-related Fatigue and Physical Activity and Their Association in Patients With Inoperable Lung Cancer: a...	University Hospital, Ghent	Observational	Recruiting	Lung Cancer (Locally Advanced or Metastatic)	50	Belgium	clinicaltrials.gov
September 1, 2026	NCT07797387	Pelvic Floor Ultrasound Before Induction of Labour and Labour Outcome	University of Roma La Sapienza	Observational	Not yet recruiting	Labor, Pelvic Floor Disorder, Labor Stage, Second, Induced Labor, Pelvic Floor, Levator Ani Muscle Injury	140	Italy	clinicaltrials.gov
August 28, 2026	NCT07793253	Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 2	Not yet recruiting	Biliary Tract Cancers, Intrahepatic Cholangiocarcinoma (Icc), Extrahepatic Cholangiocarcinoma, Gallbladder Carcinoma...	55	United States	clinicaltrials.gov
August 28, 2026	NCT07791745	A Clinical Trial Comparing the Efficacy and Safety of Anyouping® and Platinum-based Chemotherapy With or Without Enlituo® in Advanced...	Taizhou Mabtech Pharmaceutical Co.,Ltd	Phase 2/3	Recruiting	Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)	362	China	clinicaltrials.gov
August 21, 2026	NCT07780578	The Study Of Andamertinib Plus Anlotinib In Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer	Fudan University	Phase 2	Not yet recruiting	Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line	34	China	clinicaltrials.gov
August 21, 2026	NCT07778407	TDXD in Metastatic HER2-Positive Breast Cancer	Mansoura University	Observational	Completed	Breast Advanced Malignancies	25	Saudi Arabia	clinicaltrials.gov
August 19, 2026	NCT07773285	Validation of the G8 Screening Tool for Prognostic Assessment of Frailty and Early Mortality in Elderly Individuals With Cancer...	Latin American Cooperative Oncology Group	Observational	Not yet recruiting	Solid Tumor, Metastatic Solid Tumor, Recurrent Solid Tumor	250	Brazil	clinicaltrials.gov
August 19, 2026	NCT07772895	Pemefolacianine for IMI of Lung Cancer	Sunil Singhal	Phase 1	Recruiting	Lung Cancer (Locally Advanced or Metastatic)	12	United States	clinicaltrials.gov
August 13, 2026	NCT07762703	Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple...	BreakBio Corp	Phase 1/2	Not yet recruiting	Triple-Negative Breast Cancer (TNBC)	10	United States	clinicaltrials.gov
August 7, 2026	NCT07752875	A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation	LG Chem	Phase 1/2	Not yet recruiting	Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer, Colorectal Cancer, Esophageal Cancer, Breast...	250		clinicaltrials.gov
August 7, 2026	NCT07751133	Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer	University College, London	Phase 3	Recruiting	Prostate Cancer, mHSPC, mCRPC	1,500	United Kingdom	clinicaltrials.gov
August 4, 2026	NCT07746141	A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic...	BeOne Medicines	Phase 1	Recruiting	RAS Mutation, Advanced Solid Tumor, Metastatic Solid Tumor	100	Australia, New Zealand	clinicaltrials.gov
August 4, 2026	NCT07743554	Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve...	Girish Dhall, MD	Phase 2	Not yet recruiting	MPNST (Malignant Peripheral Nerve Sheath Tumor)	25		clinicaltrials.gov
July 31, 2026	NCT07738341	GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)	Eddingpharm (Zhuhai) Co., Ltd.	Phase 1/2	Not yet recruiting	Breast Cancer (Locally Advanced or Metastatic)	270		clinicaltrials.gov
July 27, 2026	NCT07728942	SLR-108 PET Imaging in Subjects With Metastatic Solid Tumors	Solve Therapeutics	Phase 1	Recruiting	Metastatic Solid Tumors	70	United States	clinicaltrials.gov
July 23, 2026	NCT07723482	ML-016 in Advanced Cancer With Lung and/or Liver Involvement	BrYet US, Inc.	Phase 1/2	Recruiting	Advanced Solid Tumor With Lung and/or Liver Involvement	108	Australia	clinicaltrials.gov
July 23, 2026	NCT07722754	Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 Trial	Guangdong Provincial People's Hospital	Phase 2	Recruiting	Colorectal Neoplasms Malignant, Neoplasm, Metastatic	160	China	clinicaltrials.gov
July 21, 2026	NCT07715903	Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump...	National Cancer Institute (NCI)	Phase 1	Not yet recruiting	Colorectal Neoplasms, Neoplasms, Intrahepatic Cholangiocarcinoma, Adrenocortical Carcinoma, Metastasis, Neoplasm	20	United States	clinicaltrials.gov
July 20, 2026	NCT07715396	Addition of Platinum-based Chemotherapy to Tislelizumab in PD-L1high Metastatic Non-small Cell Lung Cancer With a High Tumor Burden	AIO-Studien-gGmbH	Phase 3	Not yet recruiting	Non-small Cell Lung Cancer Metastatic	230	Germany	clinicaltrials.gov
July 14, 2026	NCT07703228	Second-Line Sacituzumab Tirumotecan Plus Anlotinib for Advanced Driver Gene-Negative Non-Squamous NSCLC	Nanfang Hospital, Southern Medical University	Phase 2	Active not recruiting	NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC Stage IIIB~IV, Second-line Therapy, Metastases	38	China	clinicaltrials.gov
July 14, 2026	NCT07701486	A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic Cancer	Theriva Biologics SL	Phase 1/2	Recruiting	Pancreas Cancer, Metastatic, Pancreas Cancer, Stage IV, Ductal Adenocarcinoma of the Pancreas	6	Spain	clinicaltrials.gov
July 13, 2026	NCT07697989	Pluvicto Real-world Investigation in Survival in Metastatic CRPC	Novartis Pharmaceuticals	Observational	Recruiting	Prostatic Neoplasms, Castration-Resistant, Neoplasm Metastasis	1,085	United States	clinicaltrials.gov
July 10, 2026	NCT07696832	Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or...	Guangdong Association of Clinical Trials	Observational	Recruiting	Patients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLC, EGFR...	265	China	clinicaltrials.gov
July 9, 2026	NCT07693751	A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer	SOTIO Biotech a.s.	Phase 1/2	Recruiting	Colorectal Cancer (Locally Advanced or Metastatic)	100	Moldova, United States	clinicaltrials.gov
July 6, 2026	NCT07684040	A Study of Combination Therapy in Patients With Resectable Liver Cancer	Affiliated Hospital of Guangdong Medical University	Phase 2	Not yet recruiting	Liver Cancer (Primary and Metastatic)	68	China	clinicaltrials.gov
July 6, 2026	NCT07682675	Study to Evaluate the Efficacy of Zanzalintinib in the Treatment of Relapsed or Metastatic Adenoid Cystic Carcinomas of the Head and Neck	UNICANCER	Phase 2	Not yet recruiting	Adenoid Cystic Carcinoma of the Salivary Gland, Recurrence, Metastatic Disease	51	France	clinicaltrials.gov
July 2, 2026	NCT07681882	First-in-Human Trial of DS1025a in Participants With Advanced Solid Tumors	Daiichi Sankyo	Phase 1	Recruiting	Advanced Solid Tumor, Metastatic Solid Tumor, Unresectable Solid Tumor	45	Japan	clinicaltrials.gov
July 2, 2026	NCT07680205	An Experimental Study of Belzutifan Impact on Catecholamine Metabolism	Cambridge University Hospitals NHS Foundation Trust	Phase 2	Recruiting	Pheochromocytoma and Paraganglioma (PPGL), Pheochromocytoma Malignant, Pheochromocytoma, Metastatic...	12	United Kingdom	clinicaltrials.gov
June 30, 2026	NCT07675057	Expanded Access for Vepugratinib (LY3866288) in Participants With Fibroblast Growth Factor Receptor 3 (FGFR3) Altered Solid Tumors	Eli Lilly and Company	Not applicable	Available	Urinary Bladder Neoplasms, Neoplasm Metastasis, Carcinoma, Transitional Cell	Not listed		clinicaltrials.gov
June 30, 2026	NCT07674771	Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed...	University of Texas Southwestern Medical Center	Early phase 1	Not yet recruiting	Prostate Cancer, Castration Sensitive Prostate Cancer, Metastatic Prostate Cancer, Adaptive Radiotherapy	30	United States	clinicaltrials.gov
June 29, 2026	NCT07672782	Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva	GOG Foundation	Phase 2	Not yet recruiting	Vulvar Carcinoma, Recurrent or Metastatic Vulvar Cancer, Squamous Cell Carcinoma Vulva	28	United States	clinicaltrials.gov
June 26, 2026	NCT07671768	Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Tumors, ONE SHOT Trial	Jonsson Comprehensive Cancer Center	Not applicable	Not yet recruiting	Metastatic Malignant Solid Neoplasm	25	United States	clinicaltrials.gov
June 26, 2026	NCT07671560	Efficacy and Safety of Ensartinib Combined With Anlotinib in Lorlatinib-Resistant ALK-Positive NSCLC	Qiming Wang	Phase 4	Not yet recruiting	ALK-positive, Locally Advanced or Metastatic (TNM Stage IIIB-IV) Non-small Cell Lung Cancer That Has Developed...	80		clinicaltrials.gov
June 24, 2026	NCT07665684	Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer	University Health Network, Toronto	Phase 1/2	Not yet recruiting	Pancreas Ductal Adenocarcinoma, Pancreas Cancer, Metastatic, Pancreatic Adenocarcinoma Metastatic, Adenosquamous...	67	Canada	clinicaltrials.gov
June 23, 2026	NCT07662720	A Phase II Trial for MOR Antagonism With Axelopran to Enhance Immunotherapy in Head and Neck Cancer	Glycyx Therapeutics	Phase 1/2	Not yet recruiting	Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)	18		clinicaltrials.gov
June 22, 2026	NCT07659678	CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma	Washington University School of Medicine	Phase 2	Recruiting	Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Head...	90	United States	clinicaltrials.gov
June 22, 2026	NCT07659652	Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease	University of California, San Francisco	Observational	Not yet recruiting	Breast Cancer, Quality of Life, Breast Cancer, Metastatic, Breast Cancer, Metastatic Breast Cancer, Leptomeningeal...	200	United States	clinicaltrials.gov
June 22, 2026	NCT07658768	Pilot Study of TumorGlow for Intraoperative Molecular Imaging of Sarcoma Metastases to the Lungs in Pediatric Patients	Abramson Cancer Center at Penn Medicine	Early phase 1	Recruiting	Sarcoma Metastatic	20	United States	clinicaltrials.gov
June 18, 2026	NCT07658196	TLR9 Immunotherapy for Peritoneal Carcinomatosis	Brown University	Phase 1	Recruiting	Malignant Ascites, Colorectal Adenocarcinoma, Peritoneal (Metastatic) Cancer, Appendiceal Adenocarcinoma	24	United States	clinicaltrials.gov
June 18, 2026	NCT07658183	A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone...	Shanghai Best-Link Bioscience, LLC	Phase 2	Recruiting	Breast Cancer (Locally Advanced or Metastatic)	120	China	clinicaltrials.gov
June 18, 2026	NCT07657611	Inhaled mRNA Immunotherapy for Patients With Advanced Lung Cancer or Pulmonary Metastatic Solid Tumors	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Early phase 1	Not yet recruiting	Neoplasms, Solid Tumors, Neoplasm Metastasis	60		clinicaltrials.gov
June 17, 2026	NCT07653893	A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration and Efficacy of Trastuzumab...	Fudan University	Observational	Recruiting	Central Nervous System (CNS) Metastases, Breast Cancer	60	China	clinicaltrials.gov
June 16, 2026	NCT07650786	Cell Membrane Potential Regulates Spatial-Specific Mechanoptosis Resistance and Metastasis in Colorectal Cancer Via Mechanotransduction and...	Ma Tianyi	Observational	Completed	Colorectal Cancer	4	China	clinicaltrials.gov
June 15, 2026	NCT07647328	A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer	AstraZeneca	Phase 3	Recruiting	ER-Positive HER2-Negative Breast Cancer	150	France, Germany, Italy, Poland, South Korea, Spain, Switzerland, United Arab...	clinicaltrials.gov
June 11, 2026	NCT07641023	Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC	Beijing Biotech	Phase 1/2	Recruiting	Non-Small Cell Lung Cancer, Advanced/Metastatic	60	China	clinicaltrials.gov
June 10, 2026	NCT07638878	The Efficacy of Tislelizumab Combined With Albumin-bound Paclitaxel and Platinum-based Chemotherapy in Patients With KRAS-mutated Lung...	Guangzhou Medical University	Observational	Active not recruiting	Lung Cancer (Locally Advanced or Metastatic)	30	China	clinicaltrials.gov
June 10, 2026	NCT07638371	FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers	Memorial Sloan Kettering Cancer Center	Phase 1	Recruiting	Solid Tumor, Solid Carcinoma, Advanced Solid Tumor, Unresectable Solid Tumor, Metastatic Solid Tumor	16	United States	clinicaltrials.gov
June 9, 2026	NCT07636148	Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance	Mark C Burgmans, MD PhD	Observational	Recruiting	Liver Cancer (Primary and Metastatic), Lung Cancer (Diagnosis), Bone Cancer Metastatic, Bone Cancer Tumor, Kidney...	2,000	France, Netherlands	clinicaltrials.gov
June 9, 2026	NCT07635524	A Phase 2 Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT.	Hoag Memorial Hospital Presbyterian	Phase 2	Not yet recruiting	Prostate Cancer	34	United States	clinicaltrials.gov
June 9, 2026	NCT07635147	Decision Support Tool for Patients With Advanced Breast Cancer	Weill Medical College of Cornell University	Not applicable	Recruiting	Breast Cancer Metastatic, Advanced Breast Cancer, Stage 4 Breast Cancer, Stage IV (Metastatic) Breast Cancer	100	United States	clinicaltrials.gov
June 8, 2026	NCT07631884	Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor	Haihua Yuan	Phase 2	Not yet recruiting	Solid Tumors, Neoplasms (Cancer / Tumors), Advanced Malignant Solid Neoplasm, Locally Advanced Malignant Solid...	15		clinicaltrials.gov
June 5, 2026	NCT07629960	A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations	Blueprint Medicines Corporation	Phase 1/2	Recruiting	Advanced Solid Tumor, Non-Small Cell Lung Cancer, Colorectal Neoplasms, Pancreatic Ductal Adenocarcinoma	265	Spain, United States	clinicaltrials.gov
June 4, 2026	NCT07627711	Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma	Beijing Biotech	Phase 1/2	Recruiting	Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced, Metastatic Disease	42	China	clinicaltrials.gov
June 2, 2026	NCT07621601	A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)	Hansoh BioMedical R&D Company	Phase 3	Not yet recruiting	Esophageal Squamous Cell Carcinoma (ESCC)	494		clinicaltrials.gov
June 2, 2026	NCT07621471	IL-15 Enhanced NK Cell Therapy for Solid Tumors	Genovn Therapeutics (Suzhou) Co., Ltd.	Early phase 1	Recruiting	Solid Tumors, Metastatic Cancer	12	China	clinicaltrials.gov
June 2, 2026	NCT07620951	Material Balance of [14C]Zorifertinib in Healthy Adult Male Participants in China	Alpha Biopharma (Jiangsu) Co., Ltd.	Phase 1	Completed	EGFR Mutant Advanced Non-small Cell Lung Cancer, Central Nervous System (CNS) Metastases	6	China	clinicaltrials.gov
May 29, 2026	NCT07612891	A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With...	Shenzhen Ionova Life Sciences Co., Ltd.	Phase 1/2	Recruiting	Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer, Ovarian...	201	China	clinicaltrials.gov
May 28, 2026	NCT07612176	A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors	NEOK Bio, Inc.	Phase 1	Recruiting	Locally Advanced (Unresectable) or Metastatic Solid Tumors	155	United States	clinicaltrials.gov
May 28, 2026	NCT07610798	A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced...	Shenzhen Ionova Life Sciences Co., Ltd.	Phase 1/2	Recruiting	Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC, Pancreatic Adenocarcinoma Advanced...	178	China	clinicaltrials.gov
May 27, 2026	NCT07608029	Xiaochaihu Granules for Depression After Allogeneic Hematopoietic Stem Cell Transplantation	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 2	Not yet recruiting	Depressive Disorder, Secondary, Hematopoietic Stem Cell Transplantation	46		clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Fudan University	7	September 11, 2026
Pfizer	6	October 29, 2026
Eli Lilly and Company	6	June 30, 2026
Beijing Biotech	6	June 11, 2026
UNICANCER	5	July 6, 2026
AstraZeneca	5	June 15, 2026
M.D. Anderson Cancer Center	4	April 6, 2026
Tianjin Medical University	4	November 15, 2024
Assiut University	3	October 29, 2026
BeOne Medicines	3	October 26, 2026
Regeneron Pharmaceuticals	3	October 7, 2026
Sun Yat-sen University	3	September 17, 2026
University of California, San Diego	3	September 3, 2026
Memorial Sloan Kettering Cancer Center	3	June 10, 2026
Tongji Hospital	3	May 14, 2026
British Columbia Cancer Agency	3	December 18, 2025
Yunnan Cancer Hospital	3	September 4, 2025
Azienda Ospedaliero-Universitaria di Modena	2	November 5, 2026
Crescent Biopharma, Inc.	2	November 2, 2026
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	2	October 29, 2026

By phase

Phase	New trials	Latest
Phase 1	81	October 29, 2026
Phase 2	75	October 29, 2026
Observational	68	November 5, 2026
Phase 1/2	47	November 2, 2026
Not applicable	46	November 5, 2026
Phase 3	23	October 13, 2026
Phase 2/3	10	August 28, 2026
Early phase 1	9	June 30, 2026
Phase 4	6	June 26, 2026

By country

Country	New trials	Latest
United States	149	November 2, 2026
China	93	September 30, 2026
France	45	October 29, 2026
Spain	41	July 14, 2026
Australia	31	August 4, 2026
Italy	30	November 5, 2026
Canada	27	June 24, 2026
Germany	26	September 28, 2026
South Korea	26	June 15, 2026
Japan	17	October 13, 2026
United Kingdom	17	August 7, 2026
Poland	17	June 15, 2026
Belgium	15	September 2, 2026
Brazil	13	August 19, 2026
Taiwan	13	February 11, 2026
Netherlands	11	June 9, 2026
Turkey (Türkiye)	10	November 5, 2026
Greece	8	October 27, 2026
Hungary	8	May 1, 2026
Israel	8	October 30, 2025
Romania	6	May 1, 2026
Singapore	6	April 13, 2026
Portugal	6	March 25, 2026
Argentina	6	October 30, 2025
Denmark	6	October 30, 2025

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.